Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
29.58
+1.82 (6.56%)
At close: Jul 2, 2026, 4:00 PM EDT
29.51
-0.07 (-0.25%)
After-hours: Jul 2, 2026, 7:53 PM EDT
Parabilis Medicines Employees
Parabilis Medicines had 145 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
145
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,446,248
Market Cap
3.77B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 145 | 0 | - |
| Dec 31, 2025 | 145 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 522 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| Relay Therapeutics | 193 |
| Catalyst Pharmaceuticals | 182 |
PBLS News
- 23 days ago - Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 24 days ago - Parabilis Medicines off highs, but still up over 50% from IPO price - TheFly
- 24 days ago - Parabilis Medicines opens at $33.35, IPO priced at $20.00 - TheFly
- 25 days ago - Parabilis Medicines 33.5M share IPO priced at $20.00 - TheFly
- 25 days ago - Parabilis Medicines Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire
- 25 days ago - Parabilis Medicines aims to raise $633 million in upsized US IPO - Reuters
- 4 weeks ago - Parabilis Medicines aims to raise up to $475 million in US IPO - Reuters
- 6 weeks ago - Biopharmaceutical firm Parabilis Medicines files for US IPO - Reuters